Predictive Oncology (POAI) to Release Earnings on Thursday

Predictive Oncology (NASDAQ:POAI) is expected to be announcing its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.25) per share and revenue of $0.35 million for the quarter.

Predictive Oncology Price Performance

NASDAQ:POAI opened at $1.12 on Tuesday. Predictive Oncology has a one year low of $0.55 and a one year high of $3.06. The firm’s 50 day simple moving average is $1.34 and its 200 day simple moving average is $1.00. The company has a market cap of $7.67 million, a PE ratio of -0.37 and a beta of 1.22.

Predictive Oncology Company Profile

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.